Not entirely. A generic eye drop must match the original’s active drug and strength, but its preservative, bottle and drop size can differ.
In India, a glaucoma drop can be an original brand, a branded generic or a plain generic. Regulators do not routinely require head-to-head testing of eye drops before approval. Many generics therefore have no proof that they lower pressure like the original. That is not a reason to panic. It is a reason to treat any switch as a change in treatment. Once your pressure is controlled, stay with one product and tell me if anything changes.
The differences that matter most are the preservative, the bottle design and consistency between refills. If your pressure stays controlled and your eyes stay comfortable, the brand matters less than sticking with one formulation. If you want a preservative-free option, your choice in India is usually a generic.
Read my guide: Should I Switch to Preservative-Free Glaucoma Eye Drops in India?
Why Patients Ask Me This at the Pharmacy Counter
Many patients ask the same question at the pharmacy counter. Should they buy the branded drop I wrote, or accept the cheaper generic the chemist offers? Glaucoma is not a condition where guesswork is safe.
I have seen eye pressure creep up after an unexplained switch. I have also seen patients save money on generics with no change in eye pressure. The honest answer sits between fear and dismissal. This page explains what the drops share, where they differ, and how to protect your vision either way.
What Generic and Branded Drops Share, and Where They Differ
Indian drug regulators license every glaucoma drop sold here. A generic must match the original’s active ingredient, strength and dosage form. It does not have to match the inactive formulation. That covers the preservative, the buffer and the bottle tip that sets each drop’s size.
| Factor | What It Means | What To Do About It |
|---|---|---|
| Active ingredient | Must match the original in drug and strength | Check that the molecule name on the box matches your prescription, not just the drop’s purpose |
| Preservative | A generic may use a different preservative | Tell me if your eyes sting, redden or feel gritty after a switch |
| Bottle and drop size | Bottle tips differ, and some release larger or smaller drops | Report any change in pressure control after a new bottle |
| Proof of equivalence | Indian regulators do not routinely require a patient study of eye drops | Ask which manufacturer made your batch, and stay with it |
| Cost | A generic often costs a little less, not a lot | Use any savings to take every dose, since missed doses hurt more than brand choice |
| Manufacturer consistency | Pharmacies sometimes rotate manufacturers between refills | Ask for the same manufacturer at every refill |
| Shelf life once opened | Discard dates vary by product and preservative | Follow the discard date on your label, commonly four to six weeks after opening |
The biggest real risk is not generic versus branded. It is switching products repeatedly without telling your doctor. Each switch can reset your eye’s adjustment and hide what is actually controlling your pressure.
Why Indian Rules Make This Different
The Three-Tier Indian Market for Eye Drops
In India you can choose from three options. The first is the original brand or innovator. The second is a branded generic, made by another company under its own brand name. The third is a plain generic with no recognisable brand. Patients often assume a branded generic sits closer to the original because a company name is attached. That is not necessarily true.
What Regulators Test, and What They Skip
Elsewhere, regulators tie generic approval to evidence. The US FDA waives a patient study for an eye drop solution only when its inactive ingredients match the original closely. Otherwise it asks for a clinical study. India works differently. Regulators do not routinely require a patient study for topical eye drops before approval. Many older generics were never tested head-to-head, and their inactive ingredients are often not disclosed.
Our own lab work at AIIMS found real variation in drop concentration and volume across products sold here. I therefore cannot promise that every bottle labelled latanoprost or travoprost behaves the same. I can promise to monitor your pressure closely after any change, and to flag it at once if something looks off.
My Research at AIIMS
I studied this question directly. In a lab evaluation at AIIMS, New Delhi, we tested three generic travoprost products against the branded original sold in India. Only two of the four met pharmacopoeia concentration limits. Drop volume also varied. That matters because the eye’s tear pocket holds only 7 to 10 microlitres.
In a separate review, we looked at what this means for patients. One study found intraocular pressure rose by nearly 9 percent after a switch from original latanoprost to a branded generic. It fell by over 4 percent when patients switched back. Side effects stayed similar in both groups, but the pressure shift was real. That is why I recheck pressure after any switch.
References:
Wadhwani M, Bhartiya S et al. J Curr Glaucoma Pract. 2016;10(2):49-55.
Bhartiya S, Dhingra D. Rom J Ophthalmol. 2020;64(3):239-244.
Why Using Drops Regularly Matters More Than the Brand
Glaucoma needs steady, predictable pressure control over years. Your eye adapts to a specific formulation, including its preservative load and pH. A switch, even between two approved generics, can cause temporary irritation or a small pressure shift.
I ask patients to stay with one manufacturer once we find a drop that works. It is not brand loyalty. It is pattern recognition built over months of watching your optic nerve and visual field.
Patient tip: Photograph your drop box at every refill. If the manufacturer name changes, mention it at your next visit, even if your eyes feel fine.
What Doctors Often Miss
Three things slip past many check-ups.
- A pharmacy can change your manufacturer without telling you. The label name stays the same, so nobody notices.
- A pressure rise after a switch can look like disease progression. Without the switch date, the chart tells the wrong story.
- Surface damage builds slowly. A preservative that suits you for weeks can still inflame the surface over years.
Long-Term Use Changes How We Look at Eyedrops
Most patients use glaucoma drops daily for years, often for life. For short-term use, a generic is usually a reasonable choice. Over years, ocular surface health becomes the real differentiator. Inactive ingredients, not the active drug, usually cause the gap.
A preservative that causes no issue for weeks can quietly damage the surface over years. That brings chronic dryness, irritation and poorer tolerance of the very drop that protects your vision. For lifelong therapy, I lean toward a formulation with proven long-term efficacy and tolerability, even when a cheaper option exists.
Why Some Patients Notice a Difference between Generic and Branded Eyedrops
The active drug is a fraction of what is in a bottle. For example, Latanoprost is 0.005%, that means 99.995% are excipients which keep the active ingredient stable, and are responsible for your eyes comfort as well. This 99.995% is not labelled, and not standardised. This change can reflect in drop stability, pH, viscosity etc. All of these can affect your eye pressure control, stinging, redness and long term eye health. You may notice that the bottle doesn’t last as long: that’s because the drop size may be different.
A small number of patients react to one preservative, most often benzalkonium chloride. Many older formulations contain it. If you have dry eye or ocular surface disease alongside glaucoma, a preservative-free or alternate-preservative drop may suit you better. That is a formulation decision, not a brand decision.
What I Recommend in My Practice
In most cases, I recommend the innovator drug. It comes with published efficacy and tolerability data, and in India the price gap is often small.
When cost or access is a real barrier, a generic or branded generic beats skipping doses. A patient who skips doses faces far greater risk than one on a well-monitored generic. In that case I check pressure within 4 to 6 weeks of any switch. That applies to generic to branded, branded to generic, and generic to generic.
Who Should Switch to Generics Most Carefully
Take extra care before any switch if you have:
- Advanced optic nerve damage, or only one seeing eye
- Pressure that sits close to your target
- Dry eye or ocular surface disease
In these patients, a small pressure rise carries a bigger risk. We plan the switch together and recheck early.
Please also read Should I Switch to Preservative Free Eye Drops for Glaucoma and Glaucoma progressing despite eye drops.
What You May Notice After a Switch to Generic Medication
| Symptom | Cause | When to Worry |
|---|---|---|
| New stinging, redness or grittiness | Different preservative or buffer | If it lasts beyond the first few days of the new bottle |
| Eyes feel drier over weeks | Preservative load building on the surface | If dryness continues or disturbs daily life. Tell me at your next visit |
| Higher pressure at your next check | Different drop size or formulation, missed doses, or true disease change | Any rise after a switch needs a repeat check within a few weeks |
| One eye reacts, the other does not | Local allergy or surface sensitivity | Book a visit within a week |
| Eyelid swelling, itching or rash | Allergy to the drug or preservative | Contact me promptly. Facial swelling or trouble breathing is an emergency |
When to See a Doctor
See a Doctor Urgently
Go to an eye emergency the same day if you have any of these.
- Severe eye pain with blurred vision, halos around lights, headache or vomiting
- A sudden drop in vision
- Swelling of the face or lips, or trouble breathing
See a Doctor
Contact me within a week if you notice any of these after starting or switching a drop.
- New redness, burning or stinging that lasts beyond the first few days
- New mild blur or halos without pain
- One eye reacting differently from the other
- Eyelid swelling or itching
- A pressure rise at your check-up after a formulation change
- A change in a child’s or older relative’s response, since they report symptoms less reliably
📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults
Home Measures That Protect Your Drop’s Effectiveness
- Store drops as the label says. Some need refrigeration before opening.
- Wait at least five minutes between two different drops.
- Close your eyes and press the inner corner for one minute after each drop.
- Never share a bottle, even with a relative who has glaucoma.
- Note the brand and manufacturer at every refill.
- Always check the expiry date on the label.
- Most eyedrops are to be discarded after a month of opening them.
What This Means for You
- India has three tiers of glaucoma drops: original, branded generic and plain generic. They are not automatically equivalent.
- All three share the active drug and strength. Inactive ingredients, bottle design and drop size can differ.
- Indian regulators do not routinely require patient studies of eye drops, so many generics lack head-to-head proof.
- In India, a generic often saves only 10 to 20 percent.
- Where cost allows, I recommend the innovator drug. Where it does not, a monitored generic beats skipped doses.
- Repeated switching is the real risk. Keep one manufacturer and tell me about any change.
- Pressure should be rechecked within 4 to 6 weeks of every switch.
Frequently Asked Questions
Are generic glaucoma eye drops as effective as branded ones?
Not necessarily, and this matters more in India. A generic must carry the same active ingredient at the same strength. Indian regulators do not routinely require a patient study of eye drops. Many generics therefore lack proof that they match the original’s pressure control. I recommend the innovator where cost allows. Where a generic is necessary, I recheck pressure within 4 to 6 weeks.
Is it safe to let my pharmacy substitute generics automatically?
I would not accept automatic substitution without knowing about it. If cost makes a generic necessary, ask your pharmacist to keep you on one manufacturer at every refill. Tell me whenever the brand or manufacturer changes, even if your eyes feel normal. Repeated changes make it hard to know what controls your pressure.
Do branded glaucoma drops cause fewer side effects than generics?
Not always. Side effects usually come from the preservative or other inactive ingredients, not from whether a drop is branded or generic. The innovator has published tolerability data, while many generics do not disclose their inactive ingredients. Some patients tolerate one formulation better regardless of price. That is why I ask about symptoms after every change.
How much can I save by switching to a generic glaucoma drop?
In India the saving is usually modest, often 10 to 20 percent of a monthly cost of about ₹600 to 800. That gap is smaller than many patients expect. It may not offset the uncertainty about tolerance and pressure control. Where the saving decides whether you can continue treatment, a generic is a reasonable choice with close follow-up.
Why did my eye pressure change after switching to a generic drop?
A switch can change the preservative or the drop size. Either can shift pressure. Missed doses after a switch can also raise it. In India, no routine patient study guarantees that a generic behaves like the original. A rise after switching is a signal to recheck promptly. Do not wait it out, and bring both the old and new boxes to your visit.
Book a Consultation
Choosing between a branded and a generic glaucoma drop takes more than reading the bottle. Formulation, preservative, bottle design and drop delivery can affect comfort, adherence and, for some patients, long-term control.
At my clinic in Gurgaon, I base each recommendation on your eye pressure, optic nerve, visual field, corneal thickness and treatment goals. Brand or generic is only one part of that decision.
Book a consultation if you are considering a switch, have new side effects, find your drops hard to use, or want a second opinion on your treatment plan. Bring your current drop boxes and recent pressure readings. We will review whether your drops protect your vision.
Book an Appointment:
📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults
This page is part of the Glaucoma Hub. Read about our full approach to glaucoma eye drops. Please also read Should I Switch to Preservative-Free Glaucoma Eye Drops in India?, Why Do My Eyes Burn Since Starting Glaucoma Drops? and What Is My Target Eye Pressure for Glaucoma?. Here’s another heartening patient story: Story title.
This article is part of a series of articles on Using Eyedrops, which aim to help you use your eye drops as required. You may want to read How to remember your glaucoma medication, Tips and tricks on how to use your eye drops, Whether refrigerating eye drops helps, How to manage side effects of glaucoma drops, Why my dry eye drops are not working, How to reduce glaucoma drops, Glaucoma drops not working, Should I Switch to Preservative Free Eye Drops for Glaucoma and Glaucoma progressing despite eye drops.
You may also want to learn how to put eyedrops here.
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
Dr Bhartiya has published peer-reviewed research onglaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. She is also a committed patient advocate and mainstream medical columnist, translating complex ophthalmic evidence into actionable public health insights across leading national platforms including NDTV and OnlyMyHealth
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery). Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1700+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID | Github | Wikidata
📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735
⭐ Helped by this article? Leave a Google review — it helps other patients find reliable eye care.
Last Reviewed: October 2026